{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:06:37Z","timestamp":1773324397333,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bpobgyn.2011.11.001","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T08:53:12Z","timestamp":1322815992000},"page":"233-242","source":"Crossref","is-referenced-by-count":21,"title":["New technologies for cervical cancer screening"],"prefix":"10.1016","volume":"26","author":[{"given":"Alaina J.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia L.","family":"Trimble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2011.11.001_bib1","unstructured":"American Cancer Society. Global cancer facts and figures 2007; http:\/\/www.cancer.org\/acs\/groups\/content\/@nho\/documents\/document\/globalfactsandfigures2007rev2p.pdf [last accessed 01.11.11]."},{"issue":"Suppl. 10","key":"10.1016\/j.bpobgyn.2011.11.001_bib2","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","article-title":"Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia","volume":"26","author":"Bosch","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib3","unstructured":"National Cancer Institute. SEER data for 2000\u20132004; http:\/\/seer.cancer.gov\/ [last accessed 01.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cncr.20064","article-title":"Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976\u20132000","volume":"100","author":"Wang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib5","unstructured":"American Cancer Society. Cancer facts and figures 2010; http:\/\/www.cancer.org\/acs\/groups\/content\/@nho\/documents\/document\/acspc-024113.pdf [last accessed 01.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib6","unstructured":"American Cancer Society. Cancer facts and figures for African-Americans 2009\u20132010; http:\/\/www.cancer.org\/acs\/groups\/content\/@nho\/documents\/document\/cffaa20092010pdf.pdf [last accessed 01.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib7","unstructured":"American Cancer Society. Cancer facts and figures for hispanic\/latinos 2009\u20132011; http:\/\/www.cancer.org\/acs\/groups\/content\/@nho\/documents\/document\/ffhispanicslatinos20092011.pdf [last accessed 01.11.11]."},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-9378-5-19","article-title":"HPV-immune response to infection and vaccination","volume":"5","author":"Stanley","year":"2010","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2007\/914823","article-title":"The epidemiology of human papillomavirus infection and cervical cancer","volume":"23","author":"Bosch","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/j.1349-7006.2007.00546.x","article-title":"Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins","volume":"98","author":"Narisawa-Saito","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib12","series-title":"Cervical cytology screening","year":"2009"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib14","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib15","unstructured":"Howlader N, Noone AM, Krapcho M, eds. SEER cancer statistics review, 1975\u20132008. National Cancer Institute, Bethesda, MD."},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnci\/92.5.363","article-title":"Emerging technologies and cervical cancer","volume":"92","author":"Follen","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.23489","article-title":"Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India","volume":"123","author":"Arbyn","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib18","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1016\/j.vaccine.2007.05.058","article-title":"Cost-effectiveness of HPV 16, 18 vaccination in Brazil","volume":"25","author":"Goldie","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib19","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib20","unstructured":"ASCCP. HPV genotyping clinical update 2009; http:\/\/www.asccp.org\/ConsensusGuidelines\/HPVGenotypingClinicalUpdate\/tabid\/5963\/Default.aspx [last accessed 01.11.11]."},{"issue":"Suppl. 10","key":"10.1016\/j.bpobgyn.2011.11.001_bib21","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 10","key":"10.1016\/j.bpobgyn.2011.11.001_bib22","doi-asserted-by":"crossref","first-page":"K42","DOI":"10.1016\/j.vaccine.2008.05.002","article-title":"New technologies in cervical cancer screening","volume":"26","author":"Gravitt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China","volume":"9","author":"Qiao","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/dc.21661","article-title":"Assessment of clinical and analytical performance characteristics of an HPV genotyping test","author":"Schutzbank","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib26","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.20480","article-title":"Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ","volume":"112","author":"Moberg","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib27","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/ijc.23012","article-title":"High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease","volume":"121","author":"Gravitt","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.2192","article-title":"Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?","volume":"212","author":"Pett","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/JVI.65.2.606-612.1991","article-title":"Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm","volume":"65","author":"Cullen","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jcp.50.7.600","article-title":"Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix","volume":"50","author":"Pirami","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ctrv.2008.10.005","article-title":"p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis","volume":"35","author":"Tsoumpou","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib32","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1158\/1078-0432.CCR-06-2881","article-title":"A cross-sectional study of a prototype carcinogenic human papillomavirus E6\/E7 messenger RNA assay for detection of cervical precancer and cancer","volume":"13","author":"Castle","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ijc.20839","article-title":"Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear","volume":"114","author":"Molden","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib34","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JCM.01315-10","article-title":"Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer","volume":"48","author":"Schweizer","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2008.10.012","article-title":"Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science","volume":"112","author":"Wentzensen","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib36","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1158\/1055-9965.EPI-06-0694","article-title":"Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia","volume":"16","author":"Feng","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2009.090122","article-title":"Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears","volume":"175","author":"Andersson","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib38","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62341-3","article-title":"Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer","volume":"166","author":"Heselmeyer-Haddad","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.11.001_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jcp.2004.018895","article-title":"p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer","volume":"58","author":"Murphy","year":"2005","journal-title":"J Clin Pathol"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T04:01:32Z","timestamp":1593316892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693411001623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1521693411001623"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.11.001","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}